Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
暂无分享，去创建一个
R. Houot | C. Carlo-Stella | L. Dercle | P. Brice | H. Ghesquières | E. Nicolas-Virelizier | M. Maerevoet | K. Bouabdallah | C. Herbaux | G. Manson | B. Deau | A. Stamatoullas | M. G. Silva | J. Bouteloup | J. Schiano | C. Antier | M. de Charette | F. Poizeau | E. Nicolas‐Virelizier